Union européenne -
français -
EMA (European Medicines Agency)
nuvaxovid
novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. l'utilisation de ce vaccin doit être en conformité avec les recommandations officielles. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. l'utilisation de ce vaccin doit être en conformité avec les recommandations officielles.
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
comirnaty® original/omicron ba.1 15/15 µg pro dosis gebrauchsfertige injektionsdispersion für personen ab 18 jahren comirnaty® original/omicron ba.1 15/15 µg pro dosis gebrauchsfertige injektionsdispersion für personen ab 18 jahren
pfizer ag - tozinameranum, riltozinameranum - comirnaty® original/omicron ba.1 15/15 µg pro dosis gebrauchsfertige injektionsdispersion für personen ab 18 jahren - suspension: tozinameranum 15 µg pro dosi, riltozinameranum 15 µg pro dosi, ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas), 2-(polyethylenglycoli 2000)-n,n-ditetradecylacetamidum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, saccharum, trometamolum, trometamoli hydrochloridum, aqua ad iniectabile, pro dosi. - comirnaty original/omicron ba.1 15/15 µg pro dosis gebrauchsfertige injektionsdispersion ist indiziert für die aktive immunisierung zur vorbeugung der durch das sars-cov-2-virus hervorgerufenen covid-19-erkrankung bei personen ab 18 jahren - les vaccins
Canada -
français -
Health Canada
comirnaty original & omicron ba.4/ba.5 suspension
biontech manufacturing gmbh - tozinaméran; famtozinamÉran - suspension - 15mcg; 15mcg - tozinaméran 15mcg; famtozinamÉran 15mcg
Canada -
français -
Health Canada
comirnaty original & omicron ba.4/ba.5 suspension
biontech manufacturing gmbh - tozinaméran; famtozinamÉran - suspension - 5mcg; 5mcg - tozinaméran 5mcg; famtozinamÉran 5mcg
Union européenne -
français -
EMA (European Medicines Agency)
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vaccins - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
Canada -
français -
Health Canada
comirnaty omicron xbb.1.5 suspension
biontech manufacturing gmbh - raxtozinaméran - suspension - 30mcg - raxtozinaméran 30mcg
Canada -
français -
Health Canada
comirnaty omicron xbb.1.5 suspension
biontech manufacturing gmbh - raxtozinaméran - suspension - 10mcg - raxtozinaméran 10mcg
Canada -
français -
Health Canada
comirnaty omicron xbb.1.5 suspension
biontech manufacturing gmbh - raxtozinaméran - suspension - 3mcg - raxtozinaméran 3mcg
Canada -
français -
Health Canada
nuvaxovid xbb.1.5 suspension
novavax inc. - protéine de spicule du sras-cov-2 recombinante (omicron xbb.1.5) - suspension - 5mcg - protéine de spicule du sras-cov-2 recombinante (omicron xbb.1.5) 5mcg
Canada -
français -
Health Canada
comirnaty omicron xbb.1.5 suspension
biontech manufacturing gmbh - raxtozinaméran - suspension - 10mcg - raxtozinaméran 10mcg